Preclinical Evaluation of a ⁶⁴Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma

Although the concept of theranostics is neither new nor exclusive to nuclear medicine, it is a particularly promising approach for the future of nuclear oncology. This approach is based on the use of molecules targeting specific biomarkers in the tumour or its microenvironment, associated with optim...

Descrición completa

Detalles Bibliográficos

Principais autores:	Cassandra Métivier, Patricia Le Saëc, Joëlle Gaschet, Catherine Chauvet, Séverine Marionneau-Lambot, Peter O. Hofgaard, Bjarne Bogen, Julie Pineau, Nathalie Le Bris, Raphaël Tripier, Cyrille Alliot, Férid Haddad, Michel Chérel, Nicolas Chouin, Alain Faivre-Chauvet, Latifa Rbah-Vidal
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2023-06-01
Series:	Pharmaceutics
Assuntos:	theranostics copper-64 PET imaging targeted radionuclide therapy dosimetry CD138
Acceso en liña:	https://www.mdpi.com/1999-4923/15/7/1817
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!